Predict your next investment

HEALTHCARE | Drug Manufacturing / Vitamins, Supplements & Nutraceuticals
emergenc.com

See what CB Insights has to offer

Founded Year

1972

Stage

Acquired | Acquired

About Emergen-C

Alacer is the creator of Emergen-C, a powdered drink mix supplemented with vitamin C to help support the immune system and general health.

Emergen-C Headquarter Location

80 Icon

Foothill Ranch, California, 92610,

United States

888-425-2362

Latest Emergen-C News

Ron Fugate joins Linden as Operating Partner

Mar 29, 2021

March 29, 2021 | For Immediate Release Chicago, Illinois (March 29, 2021) – Linden Capital Partners, a Chicago-based private equity firm focused exclusively on healthcare, today announced that Ron Fugate joined the firm as an Operating Partner. Mr. Fugate will support Linden’s consumer health and wellness sector effort. Mr. Fugate is an accomplished 30-year consumer products veteran CEO with deep expertise in the Vitamins, Minerals, and Supplements segment, including time spent running Perricone MD, Renew Life, Yo-Crunch, and Alacer. Most recently, Mr. Fugate served as CEO of Perricone MD, where he led the transformation of this doctor-founded beauty, skincare, and wellness business in preparation for a sale. Prior to joining Perricone MD, Mr. Fugate served as CEO/President of three privately-owned middle market CPG companies and led them through sales to strategic acquirers. In 2014, Mr. Fugate served as the CEO of Renew Life, a leader in natural digestive care products, where he guided the Company in a $290M sale to Clorox. Prior to that, he served as President of Yo-Crunch, where he launched several new products, expanded retail distribution, and drove the sale to Danone, the world’s largest yogurt company. Before Yo-Crunch, Mr. Fugate served as CEO and President of Alacer, where he helped establish Emergen-C as America’s leading branded vitamin-C supplement and led its ultimate sale to strategic acquirer Pfizer. Prior to Alacer, he held various general management and marketing roles at Zila Nutraceuticals, Bristol-Myers Squibb, Kellogg Company, and Johnson & Johnson. “We are excited for Ron to join Linden,” said Linden Co-Founder and Managing Partner Brian Miller. “His considerable experience and focus on driving revenue growth and achieving strategic exits aligns well with our approach to value creation.” “I look forward to partnering with Linden,” said Mr. Fugate. “During my tenure on the Board of Directors at MeriCal, I have been impressed with Linden’s differentiated model that integrates operating and investment experience with a focus on human capital. I am excited to work alongside the Linden team with the goal of investing in exceptional health and wellness and consumer self-care companies.” Mr. Fugate holds an MBA from Columbia University and a BS in Business Administration from Juniata College. He currently serves on the Board of Linden portfolio company MeriCal, a leading probiotic contract development and manufacturer, and he formerly served on the Executive Committee of the Council for Responsible Nutrition. He actively supports a range of charities addressing food insecurity and health science research. Latest News Linden is an investment adviser registered with the United States Securities and Exchange Commission. Linden may only transact business or render personalized investment advice in those states and international jurisdictions where it is registered, has notice filed or is otherwise excluded or exempted from registration requirements. The purpose of this web site is for information distribution on products and services. Any communications with prospective clients residing in states or international jurisdictions where Linden is not registered or licensed shall be limited so as not to trigger registration of licensing requirements. Nothing on this website is to be construed as a solicitation to offer investment advice or services. Information about investing in Linden’s funds is only available in the form of Private Placement Memorandum and other offering documents. These documents contain information to help investors evaluate Linden’s funds’ investment objectives, risks, charges and expenses, among other factors, before considering an investment. © 2021 Linden LLC. All rights reserved.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Emergen-C

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Emergen-C is included in 2 Expert Collections, including Vitamin & Supplement Startups.

V

Vitamin & Supplement Startups

623 items

C

Consumer Packaged Goods ( CPG )

4,148 items

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.